CAR T-cell therapy

About this approach

CAR T-cell therapy is a personalized cellular immunotherapy. A treatment center collects a patient’s T cells, a laboratory adds a chimeric antigen receptor that recognizes a target on cancer cells, the engineered cells are expanded, and the center returns them by infusion after lymphodepleting chemotherapy. Current approved products are used for specific leukemias, lymphomas and multiple myeloma. Treatment is coordinated through specialized hospital cellular-therapy programs because collection, manufacturing, infusion, early monitoring and long-term follow-up form one connected pathway.

Where it fits: Established cellular immunotherapy for selected leukemias, lymphomas and multiple myeloma

Where this treatment is used

Current U.S. approvals cover product-specific uses in B-cell acute lymphoblastic leukemia, several B-cell lymphomas and multiple myeloma. The target, diagnosis, age range, prior-treatment requirements and line of therapy differ by product and jurisdiction. NCI lists the established autologous products and describes solid-tumor CAR T-cell treatment as clinical research. A CAR T-cell center reviews pathology, treatment history, disease status, organ function, infection status and the practical ability to complete collection, infusion and monitoring before scheduling the pathway.

Procedure and practical considerations

The treatment pathway may include referral review, insurance or public-program authorization, testing, leukapheresis, manufacturing time, treatment to control the cancer while cells are prepared, lymphodepleting chemotherapy, CAR T-cell infusion and close monitoring. Cytokine release syndrome and neurologic toxicity can require urgent hospital treatment. Other monitored issues include infection, low blood counts, immune-system effects and secondary malignancies. The exact monitoring period, caregiver plan, driving restrictions and required distance from the center follow the product and center protocol.

Cancer guides that discuss this treatment

These cancer-type guides include this treatment among their connected approaches. Open a guide to see the related terminology, treatments, and clinic profiles.

Clinics reporting this approach

These clinic profiles mention this approach in their published materials. Open a profile to compare locations, services, practical details, and ways to get started.